Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database

被引：0
|
作者：
C. S. Karapetis
H. Liu
M. J. Sorich
L. D. Pederson
E. Van Cutsem
T. Maughan
J. Y. Douillard
C. J. O’Callaghan
D. Jonker
C. Bokemeyer
A. Sobrero
C. Cremolini
B. Chibaudel
J. Zalcberg
R. Adams
M. Buyse
M. Peeters
T. Yoshino
A. de Gramont
Q. Shi
机构：
[1] Flinders Medical Centre,Dept of Medical Oncology
[2] Flinders University,undefined
[3] Mayo Clinic,undefined
[4] University Hospitals Gasthuisberg Leuven and University of Leuven,undefined
[5] University of Liverpool,undefined
[6] University of Nantes and Integrated Centers of Oncology ICO Rene Gauducheau Cancer Nantes,undefined
[7] Canadian Cancer Trials Group,undefined
[8] The Ottawa Hospital Research Institute,undefined
[9] University Medical Center Hamburg-Eppendorf,undefined
[10] Ospedale San Martino,undefined
[11] University of Pisa,undefined
[12] Franco-British Institute Levallois-Perre,undefined
[13] Alfred Health and School of Public Health,undefined
[14] Monash University,undefined
[15] Velindre Cancer Centre Cardiff University,undefined
[16] International Drug Development Institute,undefined
[17] Antwerp University and Antwerp University Hospital,undefined
[18] National Cancer Centre Hospital East,undefined
来源：
British Journal of Cancer | 2024年 / 130卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1269 / 1278
页数：9
相关论文
共 34 条
  • [1] Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database
    Karapetis, C. S.
    Liu, H.
    Sorich, M. J.
    Pederson, L. D.
    Van Cutsem, E.
    Maughan, T.
    Douillard, J. Y.
    O'Callaghan, C. J.
    Jonker, D.
    Bokemeyer, C.
    Sobrero, A.
    Cremolini, C.
    Chibaudel, B.
    Zalcberg, J.
    Adams, R.
    Buyse, M.
    Peeters, M.
    Yoshino, T.
    de Gramont, A.
    Shi, Q.
    [J]. BRITISH JOURNAL OF CANCER, 2024, 130 (08) : 1269 - 1278
  • [2] Impact of molecular markers status on treatment effects comparing EGFR and VEGF monoclonal antibodies (mAbs) in untreated metastatic colorectal cancer (mCRC): Pooled individual patient data (IPD) analysis of randomized trials from the ARCAD database
    Karapetis, C. S.
    Liu, H.
    Sorich, M.
    Fiskum, J.
    Grothey, A.
    Adams, R. A.
    Venook, A.
    Heinemann, V.
    Lenz, H. J.
    Yoshino, T.
    Zalcberg, J. R.
    Chibaudel, B.
    Buyse, M. E.
    De Gramont, A.
    Shi, Q.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S426 - S426
  • [3] Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database
    van Rooijen, K. L.
    Shi, Q.
    Goey, K. K. H.
    Meyers, J.
    Heinemann, V.
    Diaz-Rubio, E.
    Aranda, E.
    Falcone, A.
    Green, E.
    de Gramont, A.
    Sargent, D. J.
    Punt, C. J. A.
    Koopman, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 91 : 99 - 106
  • [4] Treatment effects (TEs) of EGFR monoclonal antibodies (mAbs) in metastatic colorectal cancer (mCRC) patients (pts) with KRAS, NRAS, and BRAF mutation (MT) status: Individual patient data (IPD) meta-analysis of randomized trials from the ARCAD database.
    Karapetis, Christos Stelios
    Liu, Heshan
    Sorich, Michael
    Fiskum, Jack
    Grothey, Axel
    Van Cutsem, Eric
    Maughan, Tim
    Douillard, Jean-Yves
    Jonker, Derek J.
    Bokemeyer, Carsten
    Sobrero, Alberto F.
    Chibaudel, Benoist
    Zalcberg, John Raymond
    Adams, Richard
    Buyse, Marc E.
    De Gramont, Aimery
    Shi, Qian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] BRAFV600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database
    Cohen, Romain
    Liu, Heshan
    Fiskum, Jack
    Adams, Richard
    Chibaudel, Benoist
    Maughan, Timothy S.
    Van Cutsem, Eric
    Venook, Alan
    Douillard, Jean-Yves
    Heinemann, Volker
    Punt, Cornelis Ja
    Falcone, Alfredo
    Bokemeyer, Carsten
    Kaplan, Richard
    Lenz, Heinz-Josef
    Koopman, Miriam
    Yoshino, Takayuki
    Zalcberg, John
    Grothey, Alex
    de Gramont, Aimery
    Shi, Qian
    Andre, Thierry
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (10) : 1386 - 1395
  • [6] Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
    Franko, Jan
    Shi, Qian
    Meyers, Jeffrey P.
    Maughan, Timothy S.
    Adams, Richard A.
    Seymour, Matthew T.
    Saltz, Leonard
    Punt, Cornelis J. A.
    Koopman, Miriam
    Tournigand, Christophe
    Tebbutt, Niall C.
    Diaz-Rubio, Eduardo
    Souglakos, John
    Falcone, Alfredo
    Chibaudel, Benoist
    Heinemann, Volker
    Moen, Joseph
    De Gramont, Aimery
    Sargent, Daniel J.
    Grothey, Axel
    [J]. LANCET ONCOLOGY, 2016, 17 (12): : 1709 - 1719
  • [7] Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials
    Raimondi, Alessandra
    Nichetti, Federico
    Stahler, Arndt
    Wasan, Harpreet S.
    Aranda, Enrique
    Randon, Giovanni
    Kurreck, Annika
    Meade, Angela M.
    Diaz-Rubio, Eduardo
    Niger, Monica
    Stintzing, Sebastian
    Palermo, Federica
    Trarbach, Tanja
    Prisciandaro, Michele
    Sommerhauser, Greta
    Fisher, David
    Morano, Federica
    Pietrantonio, Filippo
    Modest, Dominik P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2023, 190
  • [8] Prognostic value of primary tumor resection in synchronous metastatic colorectal cancer (mCRC): Individual patient data (IPD) analysis of first-line randomized trials from the ARCAD database.
    Koopman, Miriam
    Shi, Qian
    Goey, Kaitlyn K. H.
    Green, Erin
    Heinemann, Volker
    Diaz-Rubio, Eduardo
    Aranda, Enrique
    Falcone, Alfredo
    De Gramont, Aimery
    Sargent, Daniel J.
    Punt, Cornelis J. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [9] Rechallenge with EGFR inhibitors in ctDNA RAS/BRAF wild type refractory metastatic colorectal cancer: Individual patients' data pooled analysis from 4 phase II trials
    Ciardiello, D.
    Mauri, G.
    Rossini, D.
    Famiglietti, V.
    Martini, G.
    Napolitano, S.
    Del Tufo, S.
    Zampino, M. G.
    Avallone, A.
    Pietrantonio, F.
    Lonardi, S.
    Santini, D.
    Masi, G.
    Siena, S.
    Bardelli, A.
    Ciardiello, F.
    Cremolini, C.
    Bianchi, A. Sartore
    Troiani, T.
    Martinelli, E.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S416 - S416
  • [10] Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials
    Faron, Matthieu
    Pignon, Jean-Pierre
    Malka, David
    Bourredjem, Abderrahmane
    Douillard, Jean-Yves
    Adenis, Antoine
    Elias, Dominique
    Bouche, Olivier
    Ducreux, Michel
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (02) : 166 - 176
1234